|
Session 131
Poster Abstracts
Genomic Mechanisms of Metabolic Complications
Tuesday, 1:30 - 3:30 pm
Poster Hall |
| 763 |
A Single Nucleotide Polymorphism in the Resistin Gene Is Associated with Adverse Metabolic Changes on HAART: An Exploratory Pharmacogenetic Association Study of A5005s, the Metabolic Sub-study of ACTG 384
Koustubh Ranade*1, R Parker1, L Ploughman1, R Parker2, P Tebas3, W Powderly4, S Grinspoon5, K Mulligan6, M Noor1,7, and M Dubé8
1Bristol-Myers Squibb, Princeton, NJ, US; 2Statistical and Data Analysis Ctr, Boston, MA, US; 3Univ of Pennsylvania, Philadelphia, US; 4Univ Coll Dublin, Ireland; 5Harvard Sch of Publ Hlth, Boston, MA, US; 6Univ of California, San Francisco, US; 7Bristol-Myers Squibb, Plainsboro, NJ, US; and 8Indiana Univ, Indianapolis, US |
| 764 |
Modeling the Influence of Polymorphisms of Several Genes Involved in Lipid Metabolism on the Risk of ART-associated Dyslipidemia
Mireia Arnedo*1, P Taffe2, H Furrer3, B Hirschel4, M Battegay5, R Weber6, P Vernazza7, E Bernasconi8, A Telenti1, P Tarr9, and Swiss HIV Cohort Study
1Inst of Microbiology, Univ of Lausanne, Switzerland; 2Swiss HIV Cohort Study Data Ctr, Lausanne; 3Univ Hosp, Berne, Switzerland; 4Geneva Univ Hosp, Switzerland; 5Univ Hosp, Basel, Switzerland; 6Univ Hosp, Zürich, Switzerland; 7Kantonsspital, St Gallen, Switzerland; 8Hosp Civico, Lugano, Switzerland; and 9Ctr Univ Hosp Vaudois, Lausanne, Switzerland |
| 765 |
Relationship of G516T Polymorphism to Lymphocyte Expression of CYP2B6
Andrew Owen*, C Cook, N Liptrott, S Khoo, and D Back
Univ of Liverpool, UK |
766
 |
The Effect of Polymorphism of the MDR-1 Gene on the Long-term Risk of Lipodystrophy and Dyslipidemia in HIV-infected Patients Starting ART
Andrea De Luca*, S Di Giambenedetto, J Schwarz, A Marzocchetti, M Colafigli, C Pinnetti, A Bacarelli, M Fantoni, and R Cauda
Catholic Univ, Rome, Italy |
| 767 |
FASl-670 and APOC3 Polymorphisms as Predictors of Lipoatrophy in Patients Receiving ART
A Cossarizza1, A Riva2, B Zanone Poma2, P Cicconi2, M Nasi1, V Broggini2, M Pinti1, A Cozzi Lepri3, A D'Arminio Monforte2, Massimo Galli*2, and LIPO I.Co.N.A. study group
1Univ Studi di Modena, Italy; 2Univ of Milan, Italy; and 3Royal Free and Univ Coll Med Sch, London, UK |
| 768 |
Association of Lipid Changes in HAART-treated Individuals with Apolipoprotein Genotypes
Edward D Gometz*1,2, D Grimm1, M King1, R Rode1, G Hanna1, B Da Silva1, and D Katz1
1Abbott Labs, Abbott Park, IL, US and 2Univ of Chicago Sch of Med, IL, US |
|
